Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Evozyne Stock

Q: How to sell Evozyne stock?

If you hold private company shares of Evozyne - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Evozyne stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

www.evozyne.com/Enterprise Software / Other Enterprise SoftwareFounded: 2020Funding to Date: $109.19MM

Evozyne, founded in 2019, is an artificial intelligence and biotechnology company that uses generative AI models with the goal of creating advanced therapeutic proteins and pharmaceuticals. The company’s platform was built on an AI model called ProT-VAE that was trained by AI hardware company Nvidia, and it is designed to read sequences on amino acids with the goal of enabling it to understand how nature assembles proteins. Evozyne is headquartered in Chicago, Illinois.

Buy or sell Evozyne stockLearn more about Evozyne IPO

OverviewFinancingsValuation

Enterprise Value

Access Evozyne’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Evozyne.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Evozyne investors also invested in these private companies

Valor Equity Partners

xAI, Neuralink, Anduril, Redwood Materials, Chime, The Boring Company, Astera Labs, Nile, Lilac Solutions, CaaStle

Fidelity Management and Research Company

Waymo, Beta Technologies, Ro, SHINE Medical Technologies, Galvanize Therapeutics, Kavak, Checkr, ABL Space Systems, Cloudflare, ApplyBoard

NVIDIA

Perplexity, CoreWeave, Waabi, Figure AI, Hugging Face, Mistral AI, Cohesity, Scale AI, Infleqtion, VAST Data

OrbiMed

ADARx Pharmaceuticals, Carrot, BioAge, Insilico Medicine, Capstan Therapeutics, Caris Life Sciences, Delfi Diagnostics, Sionna Therapeutics, Scorpion Therapeutics, Iambic Therapeutics

NVentures

Luma AI, BitGo, Jaunt, Generate Biomedicines, Neocis, Seurat, Numbrs, Vilya, Evozyne

Paragon Biosciences

Evozyne

Team

Management Team

Patrick Morris

Executive Vice President of Legal Affairs, Manager, President & General Counsel

Mike Gamson

Chief Executive Officer

Rama Ranganathan Ph.D

Co-Founder, Chief Scientific Officer & Manager

Uri Herzberg Ph.D

Chief Drug Discovery Officer

Aris Theologis

Chief Business Officer

Andrew Ferguson Ph.D

Co-Founder, Head of Computation & Computational Advisor

Zach Serber Ph.D

Chief Operating Officer

Evozyne stock FAQs

Can you buy Evozyne stock?

As Evozyne is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Evozyne, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Evozyne stock?

To invest in a private company like Evozyne through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Evozyne stock?

Yes, you may be able to sell your Evozyne stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Evozyne stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Evozyne stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Evozyne a public company?

No, Evozyne is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Evozyne’s stock price?

Evozyne is a privately held company and therefore does not have a public stock price. However, you may access Evozyne’s private market stock price with Forge Data.

What is Evozyne’s stock ticker symbol?

Evozyne does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Business Wire 09/27/2023

Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development

Evozyne announced the closing of an $81 million Series B investment round that will fund the biotech’s generative AI-powered drug discovery platform and product development. Fidelity Management & Research Company and OrbiMed led the funding with participation from NVentures, NVIDIA’s venture capital arm.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.